Building research capacity and clinical trials in developing countries

被引：6

作者：

Arai, Roberto Jun ^{[1
]}

Mano, Max Senna ^{[1
]}

de Castro, Gilberto, Jr. ^{[1
]}

Estevez Diz, Maria Del Pilar ^{[1
]}

Gehm Hoff, Paulo Marcelo ^{[1
]}

机构：

[1] Univ Sao Paulo, Fac Med, ICESP, Clin Res Unit, BR-01246000 Sao Paulo, Brazil

来源：

LANCET ONCOLOGY | 2010年 / 11卷 / 08期

关键词：

ONCOLOGY;

D O I：

10.1016/S1470-2045(10)70168-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：712 / 713

页数：2

相关论文

共 8 条

[1] [Anonymous], 2008, PLOS MED, V5, pe90
[2] Arai RJ, 2009, CLIN CANCER RES, V15, P1121, DOI 10.1158/1078-0432.CCR-08-1824
[3] Impact of therapeutic research on informed consent and the ethics of clinical trials: A medical oncology perspective
Daugherty, CK
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1601 - 1617
[4] Making Clinical data widely available
Kaiser, Jocelyn
[J]. SCIENCE, 2008, 322 (5899) : 217 - 218
[5] Spiraling costs threaten gridlock
Malakoff, David
[J]. SCIENCE, 2008, 322 (5899) : 210 - 213
[6] Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?
Mano, Max S.
Rosa, Daniela D.
Dal Lago, Lissandra
[J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (16) : 2675 - 2677
[7] Academic medical centers' standards for clinical-trial agreements with industry
Mello, MM
Clarridge, BR
Studdert, DM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (21) : 2202 - 2210
[8] 2002, B MED ETHICS, V182, P17